CNBX Pharmaceuticals

CNBX Pharmaceuticals Cannabinoid-based anti tumor Drug Candidate for the treatment of Colorectal Cancer

CNBX Pharmaceuticals is a publicly traded company (CNBX: OTCQB) and developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company's novel and proprietary formulation CNBX� RCC-33.

University of Maryland School of Medicine experts presented ChatGPT with a set of 25 questions relative to breast cancer...
05/04/2023

University of Maryland School of Medicine experts presented ChatGPT with a set of 25 questions relative to breast cancer screening recommendations. The questions asked anything from symptoms of breast cancer and who is most at risk, to costs associated with exams and how often women should undergo screening. Definitely not medical advice but an interesting platform for educating the public.

https://healthimaging.com/topics/artificial-intelligence/chatgpt-offers-recommendations-breast-cancer-screening

A team of experts with the University of Maryland School of Medicine recently presented ChatGPT with a set of questions relative to breast cancer screening recommendations to determine whether the program could reliably offer appropriate guidance.

Researchers from the University of British Columbia create an AI model that predicts cancer patient survival with greate...
03/04/2023

Researchers from the University of British Columbia create an AI model that predicts cancer patient survival with greater accuracy compared to previous methods.

https://scitechdaily.com/new-ai-model-predicts-cancer-patient-survival-more-accurately-than-previous-methods/

Researchers from the University of British Columbia and BC Cancer have created an AI model that predicts cancer patient survival with greater accuracy and using more readily accessible data compared to previous methods. The AI model utilizes natural language processing (NLP), a field of AI that c

Validation of a therapy that overcomes chemotherapy resistance in colon and re**al cancer. A recently published in the J...
31/03/2023

Validation of a therapy that overcomes chemotherapy resistance in colon and re**al cancer. A recently published in the Journal of Medicinal Chemistry, that proposes a therapeutic approach for preventing the development of resistance to chemotherapy with oxaliplatin, one of the standard treatments for colon and re**al cancer.

https://medicalxpress.com/news/2023-03-validation-therapy-chemotherapy-resistance-colon.html

A multidisciplinary team made up of doctors and scientists from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the Institute for Research in Biomedicine (IRB Barcelona) has led a study, recently published in the Journal of Medicinal Chemistry, that proposes a therapeutic...

New information from The American Journal of Human Genetics, could allow for more frequent and targeted screening to cat...
28/03/2023

New information from The American Journal of Human Genetics, could allow for more frequent and targeted screening to catch breast cancer earlier, as well as opening up more therapies or treatments that focus on genes.

https://www.ctvnews.ca/health/for-the-first-time-in-years-researchers-have-identified-a-new-susceptibility-gene-for-breast-cancer-study-1.6332519

A new gene connected to hereditary breast cancer susceptibility has been identified in what researchers are calling a landmark study.

Current or recent use of combined oral contraceptives has been associated with a small increase in breast cancer risk.LI...
21/03/2023

Current or recent use of combined oral contraceptives has been associated with a small increase in breast cancer risk.

LINK TO JOURNAL ARTICLE https://journals.plos.org/plosmedicine/article?
id=10.1371/journal.pmed.1004188

https://news.cancerresearchuk.org/2023/03/21/contraception-and-cancer/

You may have heard about a new study into contraception and cancer. New information about cancer risks can be hard to apply to everyday life, so let’s take a look at the research and break it down.

According to a Research Report by Market Research Future, the medical ma*****na market is predicted a CAGR of 31.97% dur...
08/03/2023

According to a Research Report by Market Research Future, the medical ma*****na market is predicted a CAGR of 31.97% during 2022-2030.

https://lnkd.in/eHMUctbs

According to a new study from the University of Pittsburgh and UPMC, some chemotherapy-resistant ovarian cancer cells sh...
05/03/2023

According to a new study from the University of Pittsburgh and UPMC, some chemotherapy-resistant ovarian cancer cells shield surrounding cancer cells by sending signals that generate resistance.

https://www.news-medical.net/news/20230303/Quiescent-ovarian-cancer-cells-secrete-a-protein-to-induce-chemotherapy-resistance-in-neighboring-cells.aspx

Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain why ovarian cancer patients respond poorly to chemotherapy or relapse afte...

Address

Tel Aviv

Alerts

Be the first to know and let us send you an email when CNBX Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CNBX Pharmaceuticals:

Shortcuts

Share